Sara Lingow
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sara Lingow has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Abby Lennon
Inova Bariatrics Fairfax Virginia USA
1 shared publication - Anastasia L. Armbruster
St. Louis College of Pharmacy, St. Louis, Missouri
1 shared publication - Andrew Crannage
St. Louis College of Pharmacy, St. Louis, Missouri
1 shared publication - Christina H. Sherrill
University of North Carolina Eshelman School of Pharmacy Asheville North Carolina USA
1 shared publication - Elizabeth Van Dril
University of Illinois Chicago Herbert M. And Carol H. Retzky College of Pharmacy Chicago Illinois USA
1 shared publication - Francis Anderson
St. Louis College of Pharmacy, St. Louis, Missouri
1 shared publication
Latest Publications
- 21 September 2026
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 90 (12) , 102095
Individual vs Group Performance in Integrated Pharmacotherapy Courses as Predictors of North American Pharmacist Licensure Examination Success
- 21 September 2026
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 90 (12) , 102095
Individual vs Group Performance in Integrated Pharmacotherapy Courses as Predictors of North American Pharmacist Licensure Examination Success
- Open Access
- 11 September 2025
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 8 (10) , 1078-1093
The Pharmacist's Role in the Use of Incretin‐Based Therapies for Weight Management: An Opinion of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy
The popularity of incretin‐based therapies has increased substantially over the past several years due to their clinically significant efficacy for weight loss and positive impact on weight‐related comorbid conditions, yet, few clinical practice guidelines for the management of overweight and obesity have been updated to incorporate these agents. The increased demand for incretin‐based therapies for weight management has revealed barriers to their implementation related to cost, availability, and emerging safety concerns. This opinion paper aims to briefly review the available literature on the current role of incretin‐based therapy for chronic weight management in persons with overweight or obesity and provide recommendations for clinical pharmacists utilizing these agents. The intent of this opinion paper is to discuss the benefits and risks of incretin‐based therapy for weight management, review approaches for clinical pharmacists to overcome barriers to their implementation, and address ongoing questions related to their use. Finally, the authors suggest an approach to the management of people with overweight or obesity with incretin‐based therapy using the Pharmacists' Patient Care Process along with actions clinical pharmacists can take to ensure best practices with these agents.
- 11 September 2025
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 8 (10) , 1078-1093
Open AccessThe Pharmacist's Role in the Use of Incretin‐Based Therapies for Weight Management: An Opinion of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy
The popularity of incretin‐based therapies has increased substantially over the past several years due to their clinically significant efficacy for weight loss and positive impact on weight‐related comorbid conditions, yet, few clinical practice guidelines for the management of overweight and obesity have been updated to incorporate these agents. The increased demand for incretin‐based therapies for weight management has revealed barriers to their implementation related to cost, availability, and emerging safety concerns. This opinion paper aims to briefly review the available literature on the current role of incretin‐based therapy for chronic weight management in persons with overweight or obesity and provide recommendations for clinical pharmacists utilizing these agents. The intent of this opinion paper is to discuss the benefits and risks of incretin‐based therapy for weight management, review approaches for clinical pharmacists to overcome barriers to their implementation, and address ongoing questions related to their use. Finally, the authors suggest an approach to the management of people with overweight or obesity with incretin‐based therapy using the Pharmacists' Patient Care Process along with actions clinical pharmacists can take to ensure best practices with these agents.
- Open Access
- 18 March 2024
- Published by University of Minnesota in INNOVATIONS in pharmacy
- Vol. 15 (1) , 10
Development of a Continuous Glucose Monitoring Service by Clinical Pharmacists in a Medically Underserved Population
Inspiring Inquiry and Improvement in Pharmacy Practice, Education, and Policy A quarterly publication featuring case studies, clinical experiences, commentaries, idea papers, original research, and review articles that focus on the leading edge, novel ideas for improving, modernizing, and advancing pharmacy practice, education, and policy. INNOVATIONS in pharmacy is an academic, peer reviewed, open-access journal. Sponsored by U of MN College of Pharmacy Inspiring Inquiry and Improvement in Pharmacy Practice, Education, and Policy. A quarterly publication featuring case studies, clinical experiences, commentaries, idea papers, original research, review articles, and student projects that focus on leading edge, novel ideas for improving, modernizing, and advancing pharmacy practice, education, and policy. INNOVATIONS in pharmacy.
- 18 March 2024
- Published by University of Minnesota in INNOVATIONS in pharmacy
- Vol. 15 (1) , 10
Open AccessDevelopment of a Continuous Glucose Monitoring Service by Clinical Pharmacists in a Medically Underserved Population
Inspiring Inquiry and Improvement in Pharmacy Practice, Education, and Policy A quarterly publication featuring case studies, clinical experiences, commentaries, idea papers, original research, and review articles that focus on the leading edge, novel ideas for improving, modernizing, and advancing pharmacy practice, education, and policy. INNOVATIONS in pharmacy is an academic, peer reviewed, open-access journal. Sponsored by U of MN College of Pharmacy Inspiring Inquiry and Improvement in Pharmacy Practice, Education, and Policy. A quarterly publication featuring case studies, clinical experiences, commentaries, idea papers, original research, review articles, and student projects that focus on leading edge, novel ideas for improving, modernizing, and advancing pharmacy practice, education, and policy. INNOVATIONS in pharmacy.
- 8 November 2023
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 87 (12) , 100618
Evaluation of Student Peer- and Self-Grading in an Integrated Pharmacotherapy Course
- 8 November 2023
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 87 (12) , 100618
Evaluation of Student Peer- and Self-Grading in an Integrated Pharmacotherapy Course
- 1 September 2020
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 60 (5) , 734-739
Clinical inertia among health care providers in a public health safety-net clinic in the management of type 2 diabetes
- 1 September 2020
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 60 (5) , 734-739
Clinical inertia among health care providers in a public health safety-net clinic in the management of type 2 diabetes